Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC)

Gudrun Ott1, Birte Plitzko, Carmen Krischkowski

  • 1Department of Pharmaceutical and Medicinal Chemistry, Pharmaceutical Institute, Christian-Albrechts-University of Kiel , Gutenbergstrasse 76, D-24118 Kiel, Germany.

Insights

The mARC enzyme system may reduce sulfamethoxazole hydroxylamine (SMX-HA), a step in sulfamethoxazole (SMX) drug toxicity. While mARC-1 and mARC-2 reduce SMX-HA, human variants did not show significant differences in activity.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Toxicology

Background:

  • High-dose sulfamethoxazole (SMX)/trimethoprim (TMP) treatment is linked to frequent hypersensitivity reactions.
  • The precise mechanism underlying these adverse drug reactions remains incompletely understood.
  • Investigating the toxification pathway of SMX is crucial for understanding its adverse effects.

Purpose of the Study:

  • To investigate the potential role of the mARC-containing N-reductive enzyme system in the reduction of sulfamethoxazole hydroxylamine (SMX-HA).
  • To explore the involvement of mARC-1 and mARC-2 in the SMX toxification pathway.
  • To analyze the kinetic parameters of human mARC-1 and mARC-2 variants in relation to SMX-HA reduction.

Main Methods:

  • Western blot analyses of porcine tissue subcellular fractions using antibodies against mARC-1, mARC-2, cytochrome b5 type B, and NADH cytochrome b5 reductase.
  • Incubation studies with SMX-HA using porcine and human subcellular tissue fractions and heterologously expressed human N-reductive enzyme system components.
  • mARC-1 and mARC-2 knockdown in HEK-293 cells and kinetic analysis of expressed human protein variants.

Main Results:

  • Western blot results supported the hypothesis that the mARC-containing N-reductive enzyme system is involved in SMX-HA reduction.
  • Highest reduction rates of SMX-HA were observed in mitochondrial fractions of porcine tissue and outer membrane vesicles of human liver tissue.
  • Knockdown studies confirmed that mARC-1 and mARC-2 can reduce SMX-HA in cellular metabolism, with mARC-2 exhibiting higher catalytic efficiency than mARC-1.

Conclusions:

  • The mARC-containing N-reductive enzyme system plays a role in the reduction of SMX-HA.
  • While mARC-1 and mARC-2 are capable of reducing SMX-HA, investigated human variants did not show significant differences in N-reductive activity.
  • Further research is needed to fully elucidate the role of these enzymes and their variants in SMX-induced hypersensitivity reactions.

Related Concept Videos

Preparation of Amines: Reduction of Oximes and Nitro Compounds01:29

Preparation of Amines: Reduction of Oximes and Nitro Compounds

Oximes can be reduced to primary amines using catalytic hydrogenation, hydride reduction, or sodium metal reduction. The reduction of aliphatic and aromatic nitro compounds to primary amines takes place by either catalytic hydrogenation or by using active metals like Fe, Zn, and Sn in the presence of an acid.
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
3.7K
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
794
Preparation of Amines: Reductive Amination of Aldehydes and Ketones01:38

Preparation of Amines: Reductive Amination of Aldehydes and Ketones

Carbonyl compounds and primary amines undergo reductive amination first to produce imines, followed by secondary amines in the same reaction mixture, using selective reducing agents like sodium cyanoborohydride or sodium triacetoxyborohydride. Reductive amination produces different degrees of substitution of amines depending on the starting amine substrate.
3.2K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.7K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
1.3K
Preparation of Amines: Reduction of Amides and Nitriles01:13

Preparation of Amines: Reduction of Amides and Nitriles

Nitriles can be reduced to primary amines using reducing agents like lithium aluminum hydride or catalytic hydrogenation. The reduction introduces an amino group with an extra carbon in the skeleton. Nitriles are formed from the reaction between alkyl halides and sodium cyanide through the SN2 mechanism. Primary alkyl halides are the preferred substrates to prepare nitriles.
Amides can be reduced to primary, secondary, and tertiary amines using catalytic hydrogenation, active metals like Fe,...
2.3K